helmholtzeyeinstituteРоссийский офтальмологический журналRussian Ophthalmological Journal2072-00762587-5760Real time Publishers10.21516/2072-0076-2020-13-2-12-17helmholtzeyeinstitute-420Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯCLINICAL STUDIESКлассификация капиллярной гемангиомы сетчатки на основе визуального прогнозаVisual prognosis based staging for retinal capillary hemangiomaГаргГ.GargG.

Гаурав Гарг — аспирант отдела глазных опухолей, заболеваний орбиты и офтальморадиологии

115, 61-я Ист-стрит, Нью-Йорк, 10065

Gaurav Garg — Fellow, Dept. of Ocular Tumor, Orbital Disease, Ophthalmic Radiation

115, East 61st Street , New York, NY 10065

ФингерП. Т.FingerP. T.

Поль Т. Фингер — доктор медицины, профессор офтальмологии школы медицины университета Нью-Йорка и директор службы офтальмоонкологии

115, 61-я Ист-стрит, Нью-Йорк, 10065

Paul T. Finger — Professor of Ophthalmology at the New York University School of Medicine and Director of Ocular Oncology, The New York Eye Cancer Center

115, East 61st Street , New York, NY 10065

pfinger@eyecancer.comНью-Йоркский глазной онкологический центрСоединённые Штаты АмерикиNew York Eye Cancer CenterUnited States2020260520201321217Copyright © Гарг Г., Фингер П.Т., 20202020Гарг Г., Фингер П.Т.Garg G., Finger P.T.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://roj.igb.ru/jour/article/view/420острота зрениякапиллярсетчатказрениепрогнозболезнь Гиппеля — Линдауvisual acuitycapillaryretinavisionprognosisVHLReferencesMaher E.R., Yates J.R., Harries R., et al. Clinical features and natural history of von Hippel – Lindau disease. Q. J. Med. 1990 Nov; 77 (283): 1151–63.Maher E.R., Yates J.R., Harries R., et al. Clinical features and natural history of von Hippel – Lindau disease. Q. J. Med. 1990 Nov; 77 (283): 1151–63.Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Available at: https://www.ncbi.nlm.nih.gov/pubmed/1741127Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Available at: https://www.ncbi.nlm.nih.gov/pubmed/1741127Webster A.R., Maher E.R., Moore A.T. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch. Ophthalmol. Chic. 1999 Mar; 117 (3): 371–8. doi:10.1001/archopht.117.3.371Webster A.R., Maher E.R., Moore A.T. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch. Ophthalmol. Chic. 1999 Mar; 117 (3): 371–8. doi:10.1001/archopht.117.3.371Singh A.D., Shields C.L., Shields J.A. Von Hippel – Lindau Disease. Surv Ophthalmol. 2001 Sep 1; 46 (2): 117–2. doi:10.1016/s0039-6257(01)00245-4Singh A.D., Shields C.L., Shields J.A. Von Hippel – Lindau Disease. Surv Ophthalmol. 2001 Sep 1; 46 (2): 117–2. doi:10.1016/s0039-6257(01)00245-4Singh A.D., Nouri M., Shields C.L., Shields J.A., Smith A.F. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel – Lindau disease. Ophthalmology. 2001 Oct. 1; 108 (10): 1907–11. doi:10.1016/s0161-6420(01)00758-8Singh A.D., Nouri M., Shields C.L., Shields J.A., Smith A.F. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel – Lindau disease. Ophthalmology. 2001 Oct. 1; 108 (10): 1907–11. doi:10.1016/s0161-6420(01)00758-8Wittebol-Post D., Hes F.J., Lips C.J. The eye in von Hippel – Lindau disease. Long-term follow-up of screening and treatment: recommendations. J. Intern Med. 1998 Jun; 243 (6): 555–61. doi:10.1046/j.1365-2796.1998.00338.xWittebol-Post D., Hes F.J., Lips C.J. The eye in von Hippel – Lindau disease. Long-term follow-up of screening and treatment: recommendations. J. Intern Med. 1998 Jun; 243 (6): 555–61. doi:10.1046/j.1365-2796.1998.00338.xVon Hippel – Lindau disease: case report of a patient with spontaneous regression of a retinal angioma. Available at: https://www.ncbi.nlm.nih.gov/pubmed/3554423Von Hippel – Lindau disease: case report of a patient with spontaneous regression of a retinal angioma. Available at: https://www.ncbi.nlm.nih.gov/pubmed/3554423Singh A.D., Shields J.A., Shields C.L. Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary? Arch Ophthalmol. 2001 Feb 1; 119 (2): 232–4.Singh A.D., Shields J.A., Shields C.L. Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary? Arch Ophthalmol. 2001 Feb 1; 119 (2): 232–4.Melmon K.L., Rosen S.W. Lindau’s disease: Review of the literature and study of a large kindred. Am. J. Med. 1964 Apr. 1; 36 (4): 595–617. doi: 10.1016/0002-9343(64)90107-xMelmon K.L., Rosen S.W. Lindau’s disease: Review of the literature and study of a large kindred. Am. J. Med. 1964 Apr. 1; 36 (4): 595–617. doi: 10.1016/0002-9343(64)90107-xNiemelä M., Lemeta S., Sainio M., et al. Hemangioblastomas of the retina: impact of von Hippel – Lindau disease. Invest Ophthalmol Vis Sci. 2000 Jun.; 41 (7): 1909–15.Niemelä M., Lemeta S., Sainio M., et al. Hemangioblastomas of the retina: impact of von Hippel – Lindau disease. Invest Ophthalmol Vis Sci. 2000 Jun.; 41 (7): 1909–15.Webster A.R., Maher E.R., Bird A.C., Gregor Z.J., Moore A.T. A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology. 1999 Mar; 106 (3): 623–9. doi: 10.1016/S0161-6420(99)90127-6Webster A.R., Maher E.R., Bird A.C., Gregor Z.J., Moore A.T. A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology. 1999 Mar; 106 (3): 623–9. doi: 10.1016/S0161-6420(99)90127-6McCabe C.M., Flynn H.W., Shields C.L., et al. Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology. 2000 Dec; 107 (12): 2240–8. doi: 10.1016/s0161-6420(00)00422-xMcCabe C.M., Flynn H.W., Shields C.L., et al. Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology. 2000 Dec; 107 (12): 2240–8. doi: 10.1016/s0161-6420(00)00422-xKreusel K.-M., Bechrakis N.E., Krause L., Neumann H.P.H., Foerster M.H. Retinal angiomatosis in von Hippel – Lindau disease: a longitudinal ophthalmologic study. Ophthalmology. 2006 Aug.; 113 (8): 1418–24. doi:10.1016/j.ophtha.2006.02.059Kreusel K.-M., Bechrakis N.E., Krause L., Neumann H.P.H., Foerster M.H. Retinal angiomatosis in von Hippel – Lindau disease: a longitudinal ophthalmologic study. Ophthalmology. 2006 Aug.; 113 (8): 1418–24. doi:10.1016/j.ophtha.2006.02.059Toy B.C., Agrón E., Nigam D., Chew E.Y., Wong W.T. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel Lindau disease. Ophthalmology. 2012 Dec.; 119 (12): 2622–30. doi: 10.1016/j.ophtha.2012.06.026Toy B.C., Agrón E., Nigam D., Chew E.Y., Wong W.T. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel Lindau disease. Ophthalmology. 2012 Dec.; 119 (12): 2622–30. doi: 10.1016/j.ophtha.2012.06.026Maheshwari A., Newman H., Finger P.T. Ocular Von Hippel – Lindau Disease. In: Khetan V, editor. Intraocular Tumors:145-51. Available at: https://doi.org/10.1007/978-981-15-0395-5_10Maheshwari A., Newman H., Finger P.T. Ocular Von Hippel – Lindau Disease. In: Khetan V, editor. Intraocular Tumors:145-51. Available at: https://doi.org/10.1007/978-981-15-0395-5_10Singh A.D., Nouri M., Shields C.L., Shields J.A., Perez N. Treatment of retinal capillary hemangioma. Ophthalmology. 2002 Oct.; 109 (10): 1799–806. doi:10.1016/s0161-6420(02)01177-6Singh A.D., Nouri M., Shields C.L., Shields J.A., Perez N. Treatment of retinal capillary hemangioma. Ophthalmology. 2002 Oct.; 109 (10): 1799–806. doi:10.1016/s0161-6420(02)01177-6Lane C.M., Turner G., Gregor Z.J., Bird A.C. Laser treatment of retinal angiomatosis. Eye Lond. Engl. 1989; 3 (Pt 1): 33–8. doi: 10.1038/eye.1989.5Lane C.M., Turner G., Gregor Z.J., Bird A.C. Laser treatment of retinal angiomatosis. Eye Lond. Engl. 1989; 3 (Pt 1): 33–8. doi: 10.1038/eye.1989.5Bonnet M., Garmier G. [Treatment of retinal capillary angiomas of von Hippel’s disease]. J. Fr. Ophtalmol. 1984; 7 (8-9): 545–55.Bonnet M., Garmier G. [Treatment of retinal capillary angiomas of von Hippel’s disease]. J. Fr. Ophtalmol. 1984; 7 (8-9): 545–55.Huang C., Tian Z., Lai K., et al. Long-Term therapeutic outcomes of photodynamic therapy-based or photocoagulation-based treatments on retinal capillary hemangioma. Photomed. Laser Surg. 2018 Jan.; 36 (1): 10–7. doi: 10.1089/pho.2017.4296Huang C., Tian Z., Lai K., et al. Long-Term therapeutic outcomes of photodynamic therapy-based or photocoagulation-based treatments on retinal capillary hemangioma. Photomed. Laser Surg. 2018 Jan.; 36 (1): 10–7. doi: 10.1089/pho.2017.4296Magee M.A., Kroll A.J., Lou P.L., Ryan E.A. Retinal capillary hemangiomas and von Hippel – Lindau disease. Semin Ophthalmol. 2006 Sep.; 21 (3): 143–50. doi: 10.1080/08820530500350712Magee M.A., Kroll A.J., Lou P.L., Ryan E.A. Retinal capillary hemangiomas and von Hippel – Lindau disease. Semin Ophthalmol. 2006 Sep.; 21 (3): 143–50. doi: 10.1080/08820530500350712Seibel I., Cordini D., Hager A., et al. Long-term results after proton beam therapy for retinal papillary capillary hemangioma. Am. J. Ophthalmol. 2014 Aug; 158 (2): 381–6. doi: 10.1016/j.ajo.2014.05.003Seibel I., Cordini D., Hager A., et al. Long-term results after proton beam therapy for retinal papillary capillary hemangioma. Am. J. Ophthalmol. 2014 Aug; 158 (2): 381–6. doi: 10.1016/j.ajo.2014.05.003Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998 Aug.; 105 (8): 1386–92. doi: 10.1016/S01616420(98)98017-4Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998 Aug.; 105 (8): 1386–92. doi: 10.1016/S01616420(98)98017-4Chelala E., Dirani A., Fadlallah A. Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature. Clin. Ophthalmol. Auckl. NZ. 2013; 7: 2143–6. doi: 10.2147/OPTH.S53243Chelala E., Dirani A., Fadlallah A. Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature. Clin. Ophthalmol. Auckl. NZ. 2013; 7: 2143–6. doi: 10.2147/OPTH.S53243Nordstrom–O’Brien M., Luijt R. B. van der, Rooijen E van et al. Genetic analysis of von Hippel – Lindau disease. Hum Mutat. 2010; 31 (5): 521–37. doi:10.1002/humu.21219Nordstrom–O’Brien M., Luijt R. B. van der, Rooijen E van et al. Genetic analysis of von Hippel – Lindau disease. Hum Mutat. 2010; 31 (5): 521–37. doi:10.1002/humu.21219Haddad N.M.N., Cavallerano J.D., Silva P.S. Von Hippel – Lindau disease: a genetic and clinical review. Semin. Ophthalmol. 2013 Sep 1; 28 (5–6): 377–86. doi: 10.3109/08820538.2013.825281Haddad N.M.N., Cavallerano J.D., Silva P.S. Von Hippel – Lindau disease: a genetic and clinical review. Semin. Ophthalmol. 2013 Sep 1; 28 (5–6): 377–86. doi: 10.3109/08820538.2013.825281von Buelow M., Pape S., Hoerauf H. Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol. Scand. 2007 Feb.; 85 (1): 114–6. doi: 10.1111/j.1600-0420.2006.00825.xvon Buelow M., Pape S., Hoerauf H. Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol. Scand. 2007 Feb.; 85 (1): 114–6. doi: 10.1111/j.1600-0420.2006.00825.xSlim E., Antoun J., Kourie H.R., Schakkal A., Cherfan G. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review. Can. J. Ophthalmol. J. Can. Ophtalmol. 2014 Oct.; 49 (5): 450–7. doi: 10.1016/j.jcjo.2014.07.007Slim E., Antoun J., Kourie H.R., Schakkal A., Cherfan G. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review. Can. J. Ophthalmol. J. Can. Ophtalmol. 2014 Oct.; 49 (5): 450–7. doi: 10.1016/j.jcjo.2014.07.007Albiñana V., Escribano R.M.J., Soler I., et al. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel – Lindau disease. Orphanet J. Rare Dis. 2017 29; 12 (1): 122. doi:10.1186/s13023-017-0664-7Albiñana V., Escribano R.M.J., Soler I., et al. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel – Lindau disease. Orphanet J. Rare Dis. 2017 29; 12 (1): 122. doi:10.1186/s13023-017-0664-7Wong W.T., Liang K.J., Hammel K., Coleman H.R., Chew E.Y. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel – Lindau disease. Ophthalmology. 2008 Nov.; 115 (11): 1957–64. doi: 10.1016/j.ophtha.2008.04.033Wong W.T., Liang K.J., Hammel K., Coleman H.R., Chew E.Y. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel – Lindau disease. Ophthalmology. 2008 Nov.; 115 (11): 1957–64. doi: 10.1016/j.ophtha.2008.04.033Mitropoulos P.G., Chatziralli I.P., Peponis V.G., Tsiotra V.A., Parikakis E.A. Photodynamic therapy for juxtapapillary retinal capillary hemangioma. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971562/Mitropoulos P.G., Chatziralli I.P., Peponis V.G., Tsiotra V.A., Parikakis E.A. Photodynamic therapy for juxtapapillary retinal capillary hemangioma. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971562/Parmar D.N., Mireskandari K., McHugh D. Transpupillary thermotherapy for retinal capillary hemangioma in von Hippel – Lindau disease. Ophthalmic Surg. Lasers. 2000 Aug.; 31 (4): 334–6.Parmar D.N., Mireskandari K., McHugh D. Transpupillary thermotherapy for retinal capillary hemangioma in von Hippel – Lindau disease. Ophthalmic Surg. Lasers. 2000 Aug.; 31 (4): 334–6.Schmidt-Erfurth U.M., Kusserow C., Barbazetto I.A., Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology. 2002 Jul. 1; 109 (7): 1256–66. doi: 1016/s0161-6420(02)01059-xSchmidt-Erfurth U.M., Kusserow C., Barbazetto I.A., Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology. 2002 Jul. 1; 109 (7): 1256–66. doi: 1016/s0161-6420(02)01059-xDollfus H., Massin P., Taupin P., et al. Retinal hemangioblastoma in von Hippel – Lindau disease: a clinical and molecular study. Invest. Ophthalmol. Vis. Sci. 2002 Sep. 1; 43 (9): 3067–74.Dollfus H., Massin P., Taupin P., et al. Retinal hemangioblastoma in von Hippel – Lindau disease: a clinical and molecular study. Invest. Ophthalmol. Vis. Sci. 2002 Sep. 1; 43 (9): 3067–74.Peyman G.A., Rednam K.R., Mottow-Lippa L., Flood T. Treatment of large von Hippel tumors by eye wall resection. Ophthalmology. 1983 Jul.; 90 (7): 840–7. doi: 10.1016/s0161-6420(83)34481-xPeyman G.A., Rednam K.R., Mottow-Lippa L., Flood T. Treatment of large von Hippel tumors by eye wall resection. Ophthalmology. 1983 Jul.; 90 (7): 840–7. doi: 10.1016/s0161-6420(83)34481-xWong W.T., Agrón E., Coleman H.R., et al. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel – Lindau disease. Ophthalmology. 2008 Jan.; 115 (1): 181–8. doi: 10.1016/j.ophtha.2007.03.009Wong W.T., Agrón E., Coleman H.R., et al. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel – Lindau disease. Ophthalmology. 2008 Jan.; 115 (1): 181–8. doi: 10.1016/j.ophtha.2007.03.009De Laey J.J., Hanssens M. Retinal angiomatosis – von Hippel – Lindau’s Disease. In: De Laey J.J., Hanssens M., eds. Vascular tumors and malformations of the ocular fundus. Available at: https://doi.org/10.1007/978-94-009-0589-4_2De Laey J.J., Hanssens M. Retinal angiomatosis – von Hippel – Lindau’s Disease. In: De Laey J.J., Hanssens M., eds. Vascular tumors and malformations of the ocular fundus. Available at: https://doi.org/10.1007/978-94-009-0589-4_2Vail D. Angiomatosis retinae, eleven years after diathermy coagulation. Am. J. Ophthalmol. 1958 Oct.; 46 (4): 525–34. doi: 10.1016/0002-9394(58)91132-2Vail D. Angiomatosis retinae, eleven years after diathermy coagulation. Am. J. Ophthalmol. 1958 Oct.; 46 (4): 525–34. doi: 10.1016/0002-9394(58)91132-2Sigelman J. Retinal diseases. Pathogenesis, laser therapy and surgery. Boston: Little, Brown and Company; 1984.Sigelman J. Retinal diseases. Pathogenesis, laser therapy and surgery. Boston: Little, Brown and Company; 1984.Active-Surveillance-Guidelines. Available at: https://www.vhl.org/wp-content/uploads/2017/07/Active-Surveillance-Guidelines.pdfActive-Surveillance-Guidelines. Available at: https://www.vhl.org/wp-content/uploads/2017/07/Active-Surveillance-Guidelines.pdfRuppert M.D., Gavin M., Mitchell K.T., Peiris A.N. Ocular manifestations of von Hippel-Lindau Disease. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776162/Ruppert M.D., Gavin M., Mitchell K.T., Peiris A.N. Ocular manifestations of von Hippel-Lindau Disease. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776162/Binderup M.L.M., Stendell A.-S., Galanakis M., et al. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel – Lindau disease. Br. J. Ophthalmol. 2018; 102 (7): 942–7. doi: 10.1136/bjophthalmol-2017-310884Binderup M.L.M., Stendell A.-S., Galanakis M., et al. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel – Lindau disease. Br. J. Ophthalmol. 2018; 102 (7): 942–7. doi: 10.1136/bjophthalmol-2017-310884Lamiell J.M., Salazar F.G., Hsia Y.E. von Hippel – Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989 Jan; 68 (1): 1–29. doi:10.1097/00005792-198901000-00001Lamiell J.M., Salazar F.G., Hsia Y.E. von Hippel – Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989 Jan; 68 (1): 1–29. doi:10.1097/00005792-198901000-00001Ridley M., Green J., Johnson G. Retinal angiomatosis: the ocular manifestations of von Hippel – Lindau disease. Can. J. Ophthalmol. 1986 Dec; 21 (7): 276–83.Ridley M., Green J., Johnson G. Retinal angiomatosis: the ocular manifestations of von Hippel – Lindau disease. Can. J. Ophthalmol. 1986 Dec; 21 (7): 276–83.Garcia-Arumí J., Sararols L.H., Cavero L., Escalada F., Corcóstegui B.F. Therapeutic options for capillary papillary hemangiomas. Ophthalmology. 2000 Jan.; 107 (1): 48–54. doi: 10.1016/s0161-6420(99)00018-4Garcia-Arumí J., Sararols L.H., Cavero L., Escalada F., Corcóstegui B.F. Therapeutic options for capillary papillary hemangiomas. Ophthalmology. 2000 Jan.; 107 (1): 48–54. doi: 10.1016/s0161-6420(99)00018-4McDonald H.R., Schatz H., Johnson R.N., et al. Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology. 1996 Feb.; 103 (2): 329–35. doi: 10.1016/s0161-6420(96)30696-9McDonald H.R., Schatz H., Johnson R.N., et al. Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology. 1996 Feb.; 103 (2): 329–35. doi: 10.1016/s0161-6420(96)30696-9

The authors declare that there are no conflicts of interest present.